紫杉烷
前列腺癌
医学
阉割
肿瘤科
卡巴齐塔塞尔
前列腺
内科学
睾丸切除术
化疗
雄激素
癌症
泌尿科
雄激素剥夺疗法
激素
乳腺癌
作者
Diane S. Aschenbrenner
标识
DOI:10.1097/01.naj.0000842248.30975.3f
摘要
Pluvicto (lutetium Lu 177 vipivotide tetraxetan) has been approved for the treatment of adult patients with prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer who have received androgen receptor pathway inhibition and taxane-based chemotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI